These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12514953)

  • 41. Antileishmanial activity and cytotoxicity of Brazilian plants.
    Ribeiro TG; Chávez-Fumagalli MA; Valadares DG; Franca JR; Lage PS; Duarte MC; Andrade PH; Martins VT; Costa LE; Arruda AL; Faraco AA; Coelho EA; Castilho RO
    Exp Parasitol; 2014 Aug; 143():60-8. PubMed ID: 24846006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of the 7-chloro-4-(3-hydroxy-benzilidenehydrazo)quinoline derivative against infection caused by Leishmania amazonensis.
    Antinarelli LMR; Souza MVN; Coelho EAF; Lima WP; Coimbra ES
    Rev Soc Bras Med Trop; 2020; 53():e20200091. PubMed ID: 32578713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in vivo antileishmania activity of sesquiterpene lactone-rich dichloromethane fraction obtained from Tanacetum parthenium (L.) Schultz-Bip.
    Rabito MF; Britta EA; Pelegrini BL; Scariot DB; Almeida MB; Nixdorf SL; Nakamura CV; Ferreira IC
    Exp Parasitol; 2014 Aug; 143():18-23. PubMed ID: 24810433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
    J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species.
    Inocêncio da Luz RA; Vermeersch M; Deschacht M; Hendrickx S; Van Assche T; Cos P; Maes L
    J Antimicrob Chemother; 2011 Feb; 66(2):350-3. PubMed ID: 21131319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of antileishmanial activity of harzialactone a isolated from the marine-derived fungus
    Braun GH; Ramos HP; Candido ACBB; Pedroso RCN; Siqueira KA; Soares MA; Dias GM; Magalhães LG; Ambrósio SR; Januário AH; Pietro RCLR
    Nat Prod Res; 2021 May; 35(10):1644-1647. PubMed ID: 31140307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential of doxorubicin as an antileishmanial agent.
    Sett R; Basu N; Ghosh AK; Das PK
    J Parasitol; 1992 Apr; 78(2):350-4. PubMed ID: 1556650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Liposomal-lupane system as alternative chemotherapy against cutaneous leishmaniasis: macrophage as target cell.
    Barros NB; Migliaccio V; Facundo VA; Ciancaglini P; Stábeli RG; Nicolete R; Silva-Jardim I
    Exp Parasitol; 2013 Oct; 135(2):337-43. PubMed ID: 23933281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An axenic amastigote system for drug screening.
    Callahan HL; Portal AC; Devereaux R; Grogl M
    Antimicrob Agents Chemother; 1997 Apr; 41(4):818-22. PubMed ID: 9087496
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leishmania amazonensis: effects of oral treatment with copaiba oil in mice.
    dos Santos AO; Costa MA; Ueda-Nakamura T; Dias-Filho BP; da Veiga-Júnior VF; de Souza Lima MM; Nakamura CV
    Exp Parasitol; 2011 Oct; 129(2):145-51. PubMed ID: 21771592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A nanotechnology based new approach for chemotherapy of Cutaneous Leishmaniasis: TIO2@AG nanoparticles - Nigella sativa oil combinations.
    Abamor ES; Allahverdiyev AM
    Exp Parasitol; 2016 Jul; 166():150-63. PubMed ID: 27109311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antileishmanial activity of cordiaquinone E towards Leishmania (Leishmania) amazonensis.
    Rodrigues RRL; Nunes TAL; de Araújo AR; Marinho Filho JDB; da Silva MV; Carvalho FAA; Pessoa ODL; Freitas HPS; Rodrigues KADF; Araújo AJ
    Int Immunopharmacol; 2021 Jan; 90():107124. PubMed ID: 33168414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of the clinical pulmonary surfactant Surfacen® against Leishmania amazonensis.
    Blanco O; Lugones Y; Díaz E; Monzote L
    Rev Inst Med Trop Sao Paulo; 2011; 53(4):235-8. PubMed ID: 21915470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study of the
    Azadi R; Alipour-Talesh G; Yazdanpanah MJ; Alavizadeh SH; Maleki M; Banihashemi M; Jaafari MR
    J Vector Borne Dis; 2020; 57(1):78-84. PubMed ID: 33818460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
    Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
    J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carajurin: a anthocyanidin from Arrabidaea chica as a potential biological marker of antileishmanial activity.
    Silva-Silva JV; Moragas-Tellis CJ; Chagas MSS; Souza PVR; Moreira DL; de Souza CSF; Teixeira KF; Cenci AR; de Oliveira AS; Almeida-Souza F; Behrens MD; Calabrese KS
    Biomed Pharmacother; 2021 Sep; 141():111910. PubMed ID: 34323692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
    Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antileishmanial activity of a mixture of Tridax procumbens and Allium sativum in mice.
    Gamboa-Leon R; Vera-Ku M; Peraza-Sanchez SR; Ku-Chulim C; Horta-Baas A; Rosado-Vallado M
    Parasite; 2014; 21():15. PubMed ID: 24717526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infectivity of macrophages and the histopathology of cutaneous lesions, liver and spleen is attenuated by leaf extract of Vernonia amygdalina in Leishmania major infected BALB/c mice.
    Alawa JN; Carter KC; Nok AJ; Kwanashie HO; Adebisi SS; Alawa CB; Clements CJ
    J Complement Integr Med; 2012 Jun; 9():Article 10. PubMed ID: 22713278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents.
    Agarwal A; Ramesh ; Ashutosh ; Goyal N; Chauhan PM; Gupta S
    Bioorg Med Chem; 2005 Dec; 13(24):6678-84. PubMed ID: 16126395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.